Founded in 1997, Shandong Kexing Bioproducts integrates R&D, manufacture, and sales of biopharmaceuticals. Genzon Group and Shenzhen Kexing Biotech Co. Ltd are its major stock holders.



Located in Shangdong Mingshui Development Zone in China, its production site offers Recombinant Human Erythropoietin Injection(EPO)?Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)\Filgrastim?and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and ...